Logo image of ARL

AMERICAN REALTY INVESTORS IN (ARL) Stock Fundamental Analysis

USA - NYSE:ARL - US0291741090 - Common Stock

16.42 USD
-0.3 (-1.79%)
Last: 9/19/2025, 8:04:00 PM
15.85 USD
-0.57 (-3.47%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

2

Overall ARL gets a fundamental rating of 2 out of 10. We evaluated ARL against 64 industry peers in the Real Estate Management & Development industry. While ARL seems to be doing ok healthwise, there are quite some concerns on its profitability. ARL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ARL has reported negative net income.
In the past year ARL has reported a negative cash flow from operations.
ARL had positive earnings in 4 of the past 5 years.
In multiple years ARL reported negative operating cash flow during the last 5 years.
ARL Yearly Net Income VS EBIT VS OCF VS FCFARL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

ARL's Return On Assets of -1.09% is in line compared to the rest of the industry. ARL outperforms 51.56% of its industry peers.
The Return On Equity of ARL (-1.95%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.09%
ROE -1.95%
ROIC N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ARL Yearly ROA, ROE, ROICARL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

The Gross Margin of ARL (44.96%) is better than 79.69% of its industry peers.
In the last couple of years the Gross Margin of ARL has declined.
The Profit Margin and Operating Margin are not available for ARL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
ARL Yearly Profit, Operating, Gross MarginsARL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

4

2. Health

2.1 Basic Checks

ARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARL has about the same amount of shares outstanding.
Compared to 5 years ago, ARL has more shares outstanding
Compared to 1 year ago, ARL has a worse debt to assets ratio.
ARL Yearly Shares OutstandingARL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ARL Yearly Total Debt VS Total AssetsARL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ARL has an Altman-Z score of 1.13. This is a bad value and indicates that ARL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.13, ARL perfoms like the industry average, outperforming 42.19% of the companies in the same industry.
A Debt/Equity ratio of 0.36 indicates that ARL is not too dependend on debt financing.
ARL has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.2%
ARL Yearly LT Debt VS Equity VS FCFARL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.24 indicates that ARL has no problem at all paying its short term obligations.
ARL's Current ratio of 2.24 is fine compared to the rest of the industry. ARL outperforms 65.63% of its industry peers.
ARL has a Quick Ratio of 2.24. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
ARL's Quick ratio of 2.24 is fine compared to the rest of the industry. ARL outperforms 71.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
ARL Yearly Current Assets VS Current LiabilitesARL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

0

3. Growth

3.1 Past

ARL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -419.41%.
The Revenue has decreased by -4.79% in the past year.
Measured over the past years, ARL shows a decrease in Revenue. The Revenue has been decreasing by -0.29% on average per year.
EPS 1Y (TTM)-419.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.05%
Revenue 1Y (TTM)-4.79%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%3.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARL Yearly Revenue VS EstimatesARL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARL Price Earnings VS Forward Price EarningsARL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ARL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 71.77
ARL Per share dataARL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ARL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REALTY INVESTORS IN

NYSE:ARL (9/19/2025, 8:04:00 PM)

After market: 15.85 -0.57 (-3.47%)

16.42

-0.3 (-1.79%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-05 2025-11-05
Inst Owners3.15%
Inst Owner Change-9.61%
Ins Owners0.66%
Ins Owner Change0%
Market Cap265.18M
Analysts0
Price TargetN/A
Short Float %1.65%
Short Ratio6.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.55
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA 71.77
EPS(TTM)-0.73
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.74
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS2.96
BVpS37.63
TBVpS37.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.09%
ROE -1.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.96%
FCFM N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 33.28
Cap/Depr 791.77%
Cap/Sales 201.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 1.13
F-Score2
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)243.84%
Cap/Depr(5y)175.89%
Cap/Sales(3y)69.61%
Cap/Sales(5y)51.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-419.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%142.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.79%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%3.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.91%
OCF growth 3YN/A
OCF growth 5YN/A